Skip to main content Skip to main content

NYSE: JNJ

Johnson & Johnson

Healthcare | Drug Manufacturers - General

$231.47 -2.88 (-1.23%) as of 2026-06-30 01:36 UTC

Market Cap $557.2B

Volume 2.10M

Day Range — – —

EPS (TTM) $11.03

52-Week Range

Low $146.12 High $251.71

Revenue Trend

Annual Revenue · Open in Platform →

Key Metrics

20.99

—

2.20%

+58.4%

6.83

32.87%

0.59

—

Latest News View all →

John Reed on J&J’s R&D model, oncology deals and pipeline expansion potential
Endpoints News2026-06-29NEUTRAL
Lilly, J&J, AbbVie hit new 52-week highs as healthcare outperforms
Seeking Alpha Markets2026-06-26POS
J&J CEO Now Sees 'Line of Sight' to Double-Digit Growth for His $100 Billion Company. Here's Why Investors Should Pay Attention.
fool.com2026-06-26POS
Why Johnson & Johnson, Altria, Verizon, and Other Safe Dividend Stocks Climbed Today
fool.com2026-06-23POS
STAT+: Pharmalittle: We’re reading about an FDA review of Moderna’s flu shot, J&J’s focus on cancer, and more
STAT News2026-06-18NEUTRAL

Recent Insider Activity (last 90 days)

Source: SEC EDGAR · Filed 2026-06-12 · Fetched 01:36 UTC

2026-06-12Wengel Kathryn EEVP, Chief TO and Risk OfficerM10,000$1.16M
2026-06-12Wengel Kathryn EEVP, Chief TO and Risk OfficerSELL-10,000$2.41M
2026-06-12Wengel Kathryn EEVP, Chief TO and Risk OfficerM-10,000—

Sign in to see all transactions →

Top Institutional Holders (latest 13F)

Source: SEC EDGAR · As of 2026-Q1 · Fetched 01:36 UTC

Point72 Asset Management, L.P.573,900$140.28B+375.9%
BlackRock, Inc.211,746,907$51.76B+1.4%
VANGUARD GROUP INC240,328,129$49.74B+1.6%

View QoQ ownership changes →

SEC Filings SEC EDGAR ↗

Full JNJ Analysis

SEC filings, peer comparisons, valuation models, insider transactions, debt analysis, earnings history, and more — all on Oxford Ledge.

10-Year Financials SEC EDGAR Filings AI-Powered Insights 3,500+ Tickers

Create a free account — keep JNJ